Previous Article | Next Article 
Journal of Bacteriology, October 2001, p. 5544-5553, Vol. 183, No. 19
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.19.5544-5553.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Genetics and Regulation of Chitobiose Utilization in
Borrelia burgdorferi
Kit
Tilly,1,*
Abdallah F.
Elias,1
Jennifer
Errett,1
Elizabeth
Fischer,2
Radha
Iyer,3
Ira
Schwartz,3
James L.
Bono,1,
and
Patricia
Rosa1
Laboratory of Human Bacterial
Pathogenesis1 and Microscopy
Branch,2 National Institute of Allergy and
Infectious Diseases, National Institutes of Health, Rocky Mountain
Laboratories, Hamilton, Montana 59840, and Department of
Biochemistry and Molecular Biology, New York Medical College,
Valhalla, New York 105953
Received 2 April 2001/Accepted 29 June 2001
 |
ABSTRACT |
Borrelia burgdorferi spends a significant proportion
of its life cycle within an ixodid tick, which has a cuticle containing chitin, a polymer of N-acetylglucosamine (GlcNAc). The
B. burgdorferi celA, celB, and
celC genes encode products homologous to
transporters for cellobiose and chitobiose (the dimer subunit of
chitin) in other bacteria, which could be useful for bacterial nutrient
acquisition during growth within ticks. We found that chitobiose
efficiently substituted for GlcNAc during bacterial growth in culture
medium. We inactivated the celB gene, which
encodes the putative membrane-spanning component of the transporter,
and compared growth of the mutant in various media to that of its
isogenic parent. The mutant was no longer able to utilize chitobiose,
while neither the mutant nor the wild type can utilize cellobiose. We
propose renaming the three genes chbA,
chbB, and chbC, since they probably
encode a chitobiose transporter. We also found that the
chbC gene was regulated in response to growth
temperature and during growth in medium lacking GlcNAc.
 |
INTRODUCTION |
Borrelia
burgdorferi, a Lyme disease agent, resides in the midgut of
an ixodid tick for a significant part of its natural life cycle
(17). The bacteria are acquired from an infected small
mammal when a larval tick takes its first blood meal. The spirochetes multiply within the tick as the meal is digested, and then
their numbers decline precipitously when the tick molts to the nymphal
stage (8, 21). When a nymph feeds again on a mammal (which
can be months after the larval feeding), some bacteria move to the tick
salivary glands and are transmitted to the mammal, causing a mammalian infection.
The arthropod vector undergoes a number of physiological and metabolic
changes to which resident bacteria are exposed. These changes include
blood feeding and digestion, cuticle synthesis and degradation that are
required to accommodate the blood meal and carry out the molt
(27), and tick adaptation to the resting state between
blood digestion and development of the next metamorphic stage. The
ability of B. burgdorferi to adapt to this changing environment, and to the vastly different mammalian environment, is
likely to be essential to the successful completion of an infectious cycle.
Ixodid tick integument expansion during feeding and preparation for
molting requires the synthesis of new cuticle, of which chitin, a
polymer of N-acetylglucosamine (GlcNAc), is a component (27). These ticks also have chitinous peritrophic matrices
that surround the blood meal within the midgut (24, 32).
Chitin components available during cuticle remodeling may serve as
nutrients for bacteria growing in ticks. Spirochetes require GlcNAc to
reach high densities in culture (1, 13). The genome
sequence of B. burgdorferi (12) revealed
several genes likely to facilitate chitin by-product utilization by
the bacteria. Among these are the celA, celB, and
celC genes (Fig. 1A), which
encode a phosphotransferase system (PTS) predicted to recognize
the substrate(s) chitobiose (the dimer subunit of chitin, two
-1,4-linked GlcNAc molecules) and/or cellobiose (the dimer subunit
of cellulose, two
-1,4-linked glucose molecules) (Fig. 1B). The
genome also includes a paralogous pair of genes whose products
were predicted to have
-N-acetyl-glucosaminidase (chitobiase) and/or
-glucosidase activities, which would cleave chitobiose or cellobiose into two molecules of GlcNAc or glucose, respectively.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 1.
Arrangement of chb genes and mechanism of
chitobiose transport by a PTS transporter. (A) Relative orientation of
the celB (chbC), celC
(chbA), and celA (chbB)
genes on a portion of cp26, with arrows indicating direction of
transcription. The orientation and approximate position of the
insertion of gyrBr and deletion of
chbC constructed in the chbC72 mutation
are also shown. The gyrBr gene is not drawn
to scale. (B) Expected arrangement of Chb (or Cel) proteins and
mechanism of chitobiose transport and utilization. The phosphate group
is predicted to be donated by proteins common to all PTS systems,
encoded by the chromosomal BB558, BB557, and BB448 genes
(12). Cht, chitobiase. Modified from reference
16.
|
|
The celA, celB, and celC genes (BBB06, BBB04, and BBB05,
respectively) reside on cp26 (the 26-kbp circular plasmid), whereas the
genes encoding the putative chitobiase (BB0002) and
-glucosidase (BB0620) are located on the linear chromosome (12).
Further analysis of the genome sequence predicts that B. burgdorferi can funnel free GlcNAc-6-P (resulting from transport
via a PTS system) either into glycolysis, using a putative GlcNAc-6-P
deacetylase and glucosamine-6-P isomerase, or into cell wall
biosynthesis, using a putative phosphoglucomutase (12).
Mammals contain no chitin. However, tick cuticle, which contains
chitin, is synthesized and degraded during tick development. Bacterial
numbers within ticks fluctuate during this process (21). Therefore, genes for chitobiose transport and cleavage most likely play
key roles while the bacteria reside in the tick. We have begun a study
to determine if the B. burgdorferi cel products actually
facilitate chitobiose utilization and, by extension, might help
bacteria grow in ticks. We found that chitobiose efficiently substitutes for GlcNAc in allowing B. burgdorferi
to grow to high densities in culture. In contrast, celB
mutant bacteria were unable to utilize chitobiose. We therefore propose
that the cel genes be renamed chb genes, to
reflect the sugar specificity of the encoded transporter. We also
propose that celB be renamed chbC, with
celC and celA renamed chbA and
chbB, respectively, based on the previously used rationale
in which the gene name correlates with the subunit of the PTS system
encoded thereby (14). We use these names throughout this communication.
 |
MATERIALS AND METHODS |
Bacterial strains and mutant construction.
Experiments were
performed with B31-A (4), a clone derived from
high-passage noninfectious B31 (1), or B31-4A, a reisolate derived from mouse infection with a clone of low-passage B31 (7, 9). The chbC mutant was constructed by allelic
exchange using a plasmid (pKK80) in which part of the
chbC gene had been removed and replaced with the
gyrBr gene, encoding a mutant B subunit
of gyrase that confers coumermycin A1 resistance
(23) (Fig. 1A). PKK80 was made by: (i) PCR amplifying a
4.3-kb sequence including the chbC gene and flanking
sequences (using primers cp26-24974 and cp26-20651 [Table
1]); (ii) cloning that fragment into
pCR2.1 (Invitrogen; Carlsbad, Calif.); (iii) recloning a
SpeI-XbaI fragment containing those sequences
with part of the polylinker of pCR2.1 into SpeI-digested
pOK12 (30); and (iv) replacing a 389-bp
KpnI-NcoI fragment from the chbC gene with the gyrBr gene, which had been cloned into
pCR2.1 after amplification with primers that provided those restriction
enzyme sites (U178F-KpnI and 1905R-NcoI). The
gyrBr gene is inserted in the same orientation
as the chbC gene. Recloning into pOK12 was necessary to
avoid introducing an ampicillin resistance marker into B. burgdorferi. Twenty-five micrograms of pKK80 DNA was used to
transform electrocompetent B31-A (25). The 552 resulting coumermycin A1-resistant colonies were screened for the presence of
allelic exchange by PCR using the primers chbC-F and
cp26-24116 (Table 1), and two mutants were obtained. Restriction
enzymes and T4 DNA ligase were purchased from New England Biolabs
(Beverly, Mass.).
GlcNAc assay.
The modified Morgan-Elson assay that
we used (22) is linear in the range from 0.1 to 1.6 mM
GlcNAc (where BSKII medium contains 1.8 mM GlcNAc).
To assay GlcNAc, 0.1 ml of sample was mixed with 0.1 ml of
0.8 M sodium borate and boiled for 12 min. After cooling to room
temperature, 0.55 ml of 10% Ehrlich reagent was added and the tubes
were incubated for 20 min at 37°C. After cooling again to room
temperature, the absorbance at 585 nm was compared to that of a
standard curve derived using known concentrations of GlcNAc.
Ehrlich reagent is 10% (wt/vol) p-dimethylaminobenzaldehyde in a mixture of 9 ml of glacial acetic acid and 1 ml of concentrated HCl. Ehrlich reagent (10%) was prepared by diluting the above stock
with 9 volumes of glacial acetic acid. BSKII medium and derivatives
were assayed after passing the sample through a Centricon 10 filter
(Amicon, Inc., Beverly, Mass.). Without this step, the protein in the
medium precipitated and the samples became solid after boiling. Of the
free GlcNAc found in BSKII, 50 to 80% remained in an
assayable form after this procedure.
Growth curves.
For analyzing growth in various media,
bacteria were diluted from stationary phase (2 × 108 to 4 × 108
bacteria/ml) to 105 bacteria/ml and counted daily
using a Petroff-Hausser counting chamber and a dark-field microscope.
The lowest concentration of bacteria accurately enumerated by this
method is about 105 bacteria/ml. Typical
dilutions inoculated less than 5 µl of culture into 5 ml of fresh
deficient medium, so only insignificant amounts of nutrients were
transferred with the inoculum. BSKII medium without gelatin or, in some
cases, BSK-H medium (Sigma, St. Louis, Mo.) was used. Because of
batch-to-batch medium variation and different times at which bacteria
were enumerated, experimental data could not be pooled, and
representative growth curves are shown. Experiments were repeated a
minimum of two times and often were repeated more than 10 times. In
several experiments, bacterial viability was confirmed by concentrating
the bacteria 5- to 10-fold and staining with the LIVE/DEAD BacLight
bacterial viability kit (Molecular Probes, Wilsonville, Oreg.),
according to the manufacturer's instructions. Stained cells were
visualized with a fluorescence microscope (Zeiss, Jena, Germany) and
photographed with a Nikon camera (9). On one occasion, the
numbers were also confirmed by directly assessing CFU within the
culture. In general, bacteria were enumerated until no change was
detected. In various experiments, chitobiose was a gift from S. Roseman
and N. Keyhani (Johns Hopkins University, Baltimore, Md.) or purchased
from Sigma or Seikagaku (Tokyo, Japan). The source made no discernible
difference in the results.
Northern blot analysis.
RNA was prepared and Northern
blotting was performed by previously described methods
(5). RNA was isolated from B31-A grown in medium without
GlcNAc at the peak of the first exponential phase (50 h),
during the death phase (100 h), and at the peak of the second
exponential phase (190 h). RNA was also isolated from B31-4A grown to
late exponential phase at 23°C, or from a 23°C culture diluted
100-fold, shifted to 34°C, and grown to late exponential phase (2 to
4 days). We also prepared RNA from a culture of B31-A that had been
grown to late exponential phase in BSKII lacking GlcNAc but
supplemented with 0.9 mM chitobiose. Probes were derived by PCR
(primers described in Table 1), were internal to the genes, and were
labeled with [32P]dATP by random priming
(Gibco BRL, Gaithersburg, Md.).
Southern blot analysis.
B. burgdorferi plasmid
DNA was prepared using Qiagen columns (Qiagen, Chatsworth, Calif.).
Restriction enzyme-digested or undigested DNA was separated by
electrophoresis through a 0.3% agarose gel, blotted to nylon
membranes, and hybridized as described previously (28,
29). The chbC probe was prepared by PCR (primers described in Table 1), the gyrB probe was the fragment used
for insertional inactivation, and both were labeled with
[32P]dATP by random priming (Gibco BRL).
Transmission electron microscopy.
Samples were pelleted and
fixed 1 h with 4% paraformaldehyde-2.5%
glutaraldehyde-0.1 M sodium cacodylate buffer, pH 7.4, and then
postfixed 1 h with 0.5% osmium tetroxide-0.8% potassium
ferricyanide, and then 1% tannic acid. Samples were then stained
overnight, en bloc, with 1% uranyl acetate. Samples were washed with
water and then dehydrated with a graded ethanol series and embedded in
Spurr's resin. Thin sections were cut with an RMC MT-7000
ultramicrotome (Ventana, Tucson, Ariz.) and stained with 1% uranyl
acetate and Reynold's lead citrate prior to viewing at 80 kV on a
Philips CM-10 transmission electron microscope (FEI, Hillsboro, Oreg.). Digital images were acquired with a digital camera system (Amount, Chazy, New York).
Scanning electron microscopy.
Bacterial suspension (50 µl)
was settled on 0.1% poly-L-lysine-coated Thermanox
coverslips for 30 min. Samples were fixed as described above through
dehydration. Samples were then critical point dried under
CO2 in a Bal-Tec model cpd 030 drier (Bal-Tec, Middlebury, Conn.), mounted on aluminum studs, and sputter coated with
150 Å of iridium in a model IBS/TM200S ion beam sputterer (VCR Group,
South San Francisco, Calif.) prior to examination at 5 kV in a Hitachi
S-4500 field emission scanning electron microscope (Hitachi, Tokyo, Japan)
 |
RESULTS |
B. burgdorferi utilization of chitobiose.
In order to assess the significance of the chb genes for
B. burgdorferi growth, we tested whether B. burgdorferi could use chitobiose in place of GlcNAc. To
do this, we grew clone B31-A in medium lacking GlcNAc
(normally present at 1.8 mM) but supplemented with various amounts of
chitobiose (Fig. 2). As previously
described (1, 13), the bacteria were unable to grow to
typical high density (2 × 108 to 4 × 108 bacteria per ml) in medium lacking
GlcNAc. Bacterial growth was defective when the
GlcNAc concentration was reduced to 180 µM, and lowering
the concentration to 18 µM resulted in growth indistinguishable from
that found in the absence of any added GlcNAc (data not
shown). In contrast, supplementation with as little as 18 µM
chitobiose restored normal growth and 1.8 µM chitobiose allowed
growth to near normal numbers, but 0.18 µM chitobiose had no positive
growth effect (Fig. 2). These results indicate that chitobiose
concentrations 50 to 100 times lower than those of GlcNAc
supported B. burgdorferi growth.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 2.
Growth of B31-A in medium containing various amounts of
chitobiose (chi) substituting for GlcNAc. Complete BSKII
medium contains 1.8 mM GlcNAc. Bacteria were diluted to
105/ml, grown at 35°C in the indicated media, and
enumerated daily using a Petroff-Hausser chamber and dark-field
microscope.
|
|
Temperature-shift effects on chb gene
expression.
Although mammals contain free GlcNAc and
GlcNAc monomers and oligomers as components of modifications
on proteins and other molecules (e.g., see reference 11),
they do not appear to have free chitobiose. Since chitobiose is likely
to be present in ticks, we determined if the chbC gene
conformed to the previously established correlation between temperature
regulation in vitro and gene expression within ticks or mammals
(26, 31). RNA was prepared from infectious clone B31-4A
after growth at 23°C, simulating the ambient temperature found inside
a tick, or after a shift to 34°C, more closely resembling a mammalian
environment. Northern blot analysis showed that chbC RNA is
present at a higher level at 23°C than after the shift to 34°C
(Fig. 3). Probes to the chbB
and chbA genes, which are predicted, by sequence analysis,
to be cotranscribed together with a downstream gene (Fig. 1),
hybridized to a broad band of RNA whose level was unaffected by
temperature shift (data not shown). The flaB transcript,
which was used for normalization of RNA loading (Fig. 3B), has been
previously shown to be unaltered by temperature shift (5).

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 3.
Northern blot analysis of B31-4A RNA from bacteria
before and after a temperature upshift. (A) chbC probe;
(B) flaB probe. Arrowheads indicate the 1.4-kb
chbC and 1-kb flaB mRNA positions; growth
temperatures (degrees Celsius) of cultures from which RNA was prepared
are indicated above the lanes. The exposure for the chbC
probe was approximately 10 times longer than that for the
flaB probe.
|
|
chbC gene inactivation.
For several reasons, we
chose to further analyze the importance of the chbC gene
product for utilization of chitobiose and other medium components.
First, the gene encodes the predicted membrane-spanning component of a
chitobiose transporter (Fig. 1B), without which the other components
would be ineffective. Second, the chbC gene was temperature
regulated (Fig. 3), suggesting that it might also be regulated during
bacterial growth within ticks. Third, the chbC gene has a
monocistronic transcript, so a mutation should not have polar effects.
Consequently, we mutated the gene by partial deletion and insertion of
the gyrBr gene (Fig. 1A; see Materials and
Methods). One of the two mutants obtained, chbC72, was
selected for further characterization. Southern blot (Fig.
4 and data not shown) and PCR analysis
(data not shown) confirmed that the mutant had the expected
insertion-deletion on cp26. In particular, a chbC probe
hybridized to bands in uncut or EcoRI-digested
chbC72 plasmid DNA that were appropriately larger than those
in B31-A DNA (Fig. 4, right panel). Also, a
gyrBr probe hybridized to the same bands in
chbC72 plasmid DNA and did not hybridize to B31-A plasmid
DNA (Fig. 4, left panel). To confirm the insertion site, we amplified
the chbC-gyrBr junctions from the
mutant and found that they had the expected sequences (data not shown).
The chbC mutant grew normally in complete BSKII medium (see
below).

View larger version (78K):
[in this window]
[in a new window]
|
FIG. 4.
Southern blot analysis of the chbC region
of wild-type and chbC72 bacteria. Undigested ( ) or
EcoRI-digested (R) plasmid DNA from B31-A or
chbC72 was probed with gyrB or
chbC PCR products. The wild-type gyrB
gene is chromosomal, so it is not present in these DNA preparations.
The chbC probe contains a single EcoRI
site, yielding 1.3-kbp (no longer present on the gel) and 7.5-kbp
fragments in B31-A. The insertion-deletion event leads to a net
increase of 1.7 kbp in the sizes of cp26 and of the larger
EcoRI fragment (which becomes 9.2 kbp). Sizes (in
kilobase pairs) corresponding to migration positions of DNA standards
are indicated on the left.
|
|
Growth in various derivatives of BSKII medium.
Although
GlcNAc is an essential component of BSKII medium (1,
13), the medium also contains several other potential sources of
complexed GlcNAc. Yeastolate, an enzymatic digest of yeast (which has a chitinous cell wall) probably contains chito-oligomers. Serum includes glycosylated proteins with
GlcNAc-containing modifications (e.g., see reference
11), glycolipids, and possibly other
GlcNAc-containing molecules, which could supply
GlcNAc. Using the Morgan-Elson assay for GlcNAc
(22), we found that neither serum nor yeastolate contributes significant free GlcNAc (data not shown). Gelatin is a nonessential ill-defined product derived from animals and, therefore, was omitted in most experiments. In an attempt to separate the contributions of various GlcNAc sources, we assayed
the growth of the B. burgdorferi wild type and
chbC mutant in BSKII medium lacking GlcNAc,
yeastolate, and both (Fig.
5).
In medium lacking yeastolate, wild-type and chbC mutant
bacteria both grew more slowly than in complete medium, but to almost
the same density (Fig. 5A).





View larger version (80K):
[in this window]
[in a new window]
|
FIG. 5.
Growth of B31-A and the chbC72 mutant in
various media. (A) Growth in BSKII with and without yeastolate (ye).
(B) Growth in BSKII with and without GlcNAc. (C)
Growth in BSKII with and without GlcNAc, and with the substitution
of chitobiose (chi) (1.8 mM) for GlcNAc. (D) Growth of
low-passage B31-4A in BSKII with and without GlcNAc, and with
the substitution of chitobiose (chi) (1.8 mM) for GlcNAc.
E. Growth in BSKII with and without both yeastolate (ye) and
GlcNAc. Bacteria were enumerated as for Fig. 2.
Representative experiments are shown.
|
|
In medium lacking GlcNAc, both strains had complex
growth patterns (Fig.
5B). After dilution to
10
5 bacteria/ml, both grew to
~10
7 bacteria/ml, and then the numbers of
viable bacteria dropped
precipitously (death phase). After the death
phase, the wild-type
bacteria began a second exponential phase, at a
somewhat lower
growth rate, and finally achieved bacterial numbers
comparable
to or greater than those found in the first exponential
phase.
In contrast, the
chbC mutant did not grow further.
Although chitobiose
efficiently substituted for GlcNAc for
wild-type bacterial growth
(Fig.
2 and Fig.
5C), growth of the
chbC72 mutant was not restored
by the addition of
chitobiose (Fig.
5C). Cellobiose (at 1.8 mM)
did not restore the
growth of either the wild-type or the
chbC mutant
bacteria (data not shown). The low-passage infectious clone
B31-4A
had the same growth pattern as high-passage B31-A during
growth in
these media (Fig.
5D), as did BL224, a clinical isolate
from a patient
in the early stages of Lyme disease (data not
shown).
Although previous studies had shown 90% lower bacterial yield in
medium lacking GlcNAc (
1,
13), these authors did
not
describe the complex growth pattern that we observed. The initial
growth, death, and second exponential growth phases were all
unanticipated,
and our subsequent experiments were designed to help
understand
what bacterial genes and medium components contributed to
these
phases.
In medium lacking both GlcNAc and yeastolate (Fig.
5E), both
strains grew to about 10
7 bacteria/ml, died, and
did not grow further. This growth pattern
was the same as that found
for the
chbC mutant in medium lacking
only GlcNAc.
We conclude that the second exponential phase requires
the
chbC gene product and involves utilization of a component
of
yeastolate (perhaps
chitobiose).
Morphological analysis of bacteria by dark-field microscopy and
scanning and transmission electron microscopy revealed the
dramatic
changes that both the wild-type and
chbC mutant bacteria
undergo in medium lacking GlcNAc. At the peak of the first
exponential
phase, most wild-type and
chbC mutant bacteria
had round membrane-bound
masses near their midpoints (Fig.
6A, B, I, and J). Transmission
electron
microscopy (Fig.
6I and J) showed that the membrane surrounding
the
masses was contiguous with that surrounding the rest of the
spirochetes
and that the cytosolic contents of the masses were
less electron dense
than in the rest of the spirochete. In some
cases, membranes with
discontinuities appeared to partially separate
the masses from the
bodies of the spirochetes and disrupted flagellar
bundles were
detected. These masses differ from previously described
gemmae
(
2), which have well-defined contents, and spheroplasts
(
6,
10), which aggregate and have numerous extended
flagella.
They do resemble, however, structures also called
spheroplasts
that were formed after treating
Borrelia
hermsii or
B. burgdorferi with penicillin (
3,
8a). During the death phase, all bacteria
had a
progressively more amorphous structure and assumed a less
refractile
appearance, and most eventually disappeared and presumably
lysed (Fig.
6C and D). Wild-type bacteria in the second exponential
phase looked
normal by microscopic examination (Fig.
6E). By dark-field
examination,
few if any viable spirochetes were found at the equivalent
time in
cultures of the
chbC mutant, and particulate structures
observed by scanning electron microscopy (Fig.
6F) were probably
medium
components, since preparations of BSKII medium without
spirochetes
looked the same (data not shown). Wild-type or
chbC mutant
bacteria grown for the same amount of time in complete
medium retained
typical morphology (Fig.
6G and H), although their
motility diminished
with time.

View larger version (169K):
[in this window]
[in a new window]
|
FIG. 6.
Scanning (A to H) and transmission (I and J) electron
microscopic appearance of B31-A (A, C, E, G, and I) and
chbC72 (B, D, F, H, and J) bacteria at various times
during growth in medium with or without GlcNAc.
Bacteria are shown at 50 h, representing the first
exponential phase (A, B, I, and J); at 100 h, representing the
death phase (C and D); and at 215 h, representing the second
exponential phase for wild type bacteria (E and F). (G and H)
Spirochetes from cultures grown in complete BSKII for 215 h. Scale
bars = 1 µm.
|
|
One possible explanation for the second exponential phase was that the
bacteria able to grow had acquired an undefined mutation,
selected by
growth in the absence of GlcNAc. To address this possibility,
we diluted a culture from this phase back into medium with or
without
GlcNAc (Fig.
7). In medium
lacking GlcNAc, the bacteria
exhibited the same growth
pattern as previously (i.e., with first
exponential, death, and second
exponential phases), excluding
the possibility of a mutant population
(Fig.
7). This experiment
also shows that the bacterial adaptation that
leads to the second
exponential phase is lost after growth in fresh
BSKII lacking
GlcNAc. Finally, the bacterial number achieved
in the second exponential
phase in this and many other experiments is
higher than in the
first exponential phase. This higher density would
not be achieved
if scavenging of dead bacteria from the first
exponential phase
were the only source of an essential nutrient for
growth.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 7.
Growth during first and second passages in BSKII without
GlcNAc. B31-A bacteria were diluted to 105/ml in
BSKII without GlcNAc, grown for 214 h (to the second
exponential phase), and then diluted back to 105/ml in
BSKII without GlcNAc (arrows). The same culture was also
diluted into medium with GlcNAc, both at the
t = 0 time point and at 214 h. Bacteria were
enumerated as for Fig. 2.
|
|
chbC expression during growth without
GlcNAc.
Induction of the chbC gene (or
another gene required for chitobiose utilization) in response to
the absence of GlcNAc during growth in BSKII lacking
GlcNAc might explain why the wild-type bacteria exhibit a
complex growth pattern in this medium. To address this possibility, we
used Northern blot analysis to compare chbC expression at
various times during growth without GlcNAc to expression in
BSKII complete medium (Fig. 8). RNA was
prepared from B31-A at the peak of the first exponential phase (50 h),
during the death phase (100 h), and at the peak of the second
exponential phase (190 h) (indicated on growth curves in Fig. 8A).
chbC transcript was present at higher levels in bacteria
from the second exponential phase (Fig. 8B, lane 5), as expected from
the growth characteristics of wild-type and mutant bacteria in various
depleted media. After normalizing to the constitutively expressed
flaB transcript level (Fig. 8C), induction of
chbC expression during the second exponential phase was
about 60-fold over that found in bacteria grown in BSKII complete
medium (Fig. 8B, lane 1). When B31-A was grown without GlcNAc
but with the addition of enough chitobiose (0.9 mM) to contribute an
equivalent molar amount of GlcNAc (Fig. 8B, lane 2),
chbC transcript was present at a level similar to that found during growth in normal BSKII medium (Fig. 8B, lane 1).

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 8.
Northern blot analysis of RNA prepared from B31-A
bacteria grown in BSKII medium lacking GlcNAc, with and
without chitobiose supplementation. (A) Growth curves, with numbers
(corresponding to lanes in B and C) and arrows indicating times at
which RNA was prepared. The solid line indicates B31-A grown in
complete BSKII medium, the dotted line indicates growth in BSKII
without GlcNAc, and the dashed line indicates growth in BSKII
lacking GlcNAc but supplemented with chitobiose. (B and C) Northern
blot analysis of RNA from the indicated time points. Lanes: 1, bacteria
grown in complete BSKII; 2, bacteria grown in BSKII without
GlcNAc supplemented with 0.9 mM chitobiose; 3 to 5, bacteria
grown in BSKII without GlcNAc, with RNA isolated from
the first exponential phase, the death phase, and the second
exponential phase, respectively. The blot was hybridized first with a
chbC probe (arrowhead in panel B) and then rehybridized
with a flaB probe (arrowhead in panel C). The exposure
for the chbC probe was approximately 10 times longer
than that for the flaB probe. Densitometric comparison
of the flaB hybridization signals indicated that lanes 1 and 2 contained threefold more RNA than lanes 3 to 5.
|
|
 |
DISCUSSION |
We have undertaken an analysis of chbC gene function
because we suspect that its product, along with those of the
chbA and chbB genes, is important for bacterial
growth within ticks. The studies described here support that idea,
since the chbC gene product is required for utilization of
chitobiose, a compound likely to be present in ticks but not found free
in mammalian tissues. In other bacteria, chitobiose transporters are
encoded in combination with secreted and periplasmic chitinases that
can release chitobiose as a degradation product (15). In
marine bacteria, which live in environments replete in
chitin-containing material, the transporters are used for nutrient
acquisition. B. burgdorferi does not contain a homolog of
known chitinases but may instead rely on release of chitobiose by its
tick host for a nutrient source.
Our model for explaining the unusual growth of B. burgdorferi in medium lacking GlcNAc is the
following. The first exponential phase growth involves utilization
of GlcNAc recycled from nonessential bacterial components, which
become depleted. Despite the loss of available GlcNAc for
cell wall biosynthesis, the bacteria continue to grow, and most
eventually lyse because of compromised cell wall integrity
(see, e.g., reference 19). Some of the bacteria survive,
however, through increased expression of the chbC gene so that they can now utilize chito-oligomers,
present at low concentration in yeastolate, to supply GlcNAc.
Support for this model is as follows: the lack of the second
exponential phase in the chbC mutant suggests that the ChbC
protein (and presumably the ChbA and ChbB proteins) is required for
this growth. Consistent with this idea is the increased chbC
transcript observed at that time. The absence of a second exponential
phase in medium lacking both GlcNAc and yeastolate suggests
that yeastolate contributes a nutrient essential for this growth,
presumably chito-oligomers. The ability of chitobiose to substitute for
GlcNAc in the wild type, but not the chbC mutant,
suggests that the Chb products are essential for chitobiose utilization.
We have found that lowering the level of GlcNAc in BSKII
medium to 10% of normal led to poor bacterial growth in culture
(data not shown). In contrast, chitobiose levels equivalent to
100-fold-lower GlcNAc concentrations sufficed for normal
bacterial growth (Fig. 1), perhaps because the bacteria have a
transporter specific for chitobiose but not for GlcNAc. If
the cellular GlcNAc content of B. burgdorferi is
similar to that of E. coli, then this low amount of
chitobiose would be almost completely consumed in the process of
bacterial multiplication from 105 to 2 × 108 cells per ml, suggesting that chitobiose
is very efficiently utilized by B. burgdorferi. Cellobiose
did not support bacterial growth, probably because it is not a
source of GlcNAc, even if successfully transported and cleaved.
The abnormal morphology of the bacteria during the death phase (Fig. 6
and data not shown) is consistent with loss of cell wall integrity
coupled with continuing membrane synthesis and suggests that a critical
function of GlcNAc is as a cell wall precursor. The
clustering of the gene encoding a putative chitobiase (BB0002), the
enzyme that cleaves chitobiose to free GlcNAc, with other
genes encoding homologs of products involved in cell wall biosynthesis
(see the introduction) is also consistent with this interpretation.
B. burgdorferi also has a paralogous gene (BB0620) whose
product may be involved in chitobiose utilization (12). Although the levels of sequence similarity between these genes and
those of other bacteria do not permit us to assign functions to
their products, our preliminary results (data not shown) suggest that the BB0002 product is not required for chitobiose utilization, either because it recognizes a different substrate or because a
redundant activity is encoded elsewhere.
B. burgdorferi within ticks exhibit a growth pattern
parallel to the one that we describe in medium lacking GlcNAc
(21). After Ixodes scapularis larvae feed on
infected mice, the bacterial load in the tick midgut increases to
several thousand spirochetes per tick and then drops to prefeeding
levels as the ticks molt. When the infected ticks next feed as nymphs,
the number of spirochetes in the midgut increases over 100-fold and
then plummets once again when the nymphs molt to adult ticks. Piesman
et al. (21) suggested that this growth pattern may be
caused by limited GlcNAc availability when the ticks are
actively synthesizing new chitinous cuticle during the molting process.
Bacteria with membrane-bound masses resembling those seen during
GlcNAc limitation (Fig. 6) have been observed in unfed
nymphal ticks that were infected as larvae (T. Schwan, personal
communication). These bacteria have survived the stress that led to
their population decline during the molt, and their structure may
reflect a response to that stress.
B. burgdorferi growth characteristics within ticks directly
affect successful maintenance of a bacterial infectious cycle. The
number of spirochetes within ticks (18, 20, 21) as well as
surface protein phenotype (e.g., see reference 18) affects transmission to mammals. Here, we initiate a study into factors affecting spirochete growth by studying genes whose products are reasonably expected to play roles in bacterial metabolism
within ticks. We investigated bacterial growth in the presence of
limiting chitobiose or GlcNAc, culture conditions that mimic
possible stresses encountered by the bacteria during life within the
tick vector. Our results confirm that bacterial utilization of
chitobiose as a source of GlcNAc is dependent on the activity
of the plasmid-borne chbC gene, which encodes a component of
a putative PTS transporter. Studying the physiological and
regulatory consequences of chitin component metabolism will
increase our understanding of the dynamic interactions between tick and
spirochete that are pertinent to transmission of bacteria to a mammal.
 |
ACKNOWLEDGMENTS |
We thank Janice McClory for preparing BSKII medium
lacking various components. Tom Schwan provided help with fluorescence microscopy, and we also thank him for drawing our attention to and
permitting us to describe similarities between spirochetes in flat
ticks and spirochetes grown in medium lacking GlcNAc. Daniel
Hogan helped with DNA sequencing. G. Somerville, M. Chaussee, J. M. Musser, T. Schwan, S. Kustu, and J. Hinnebusch provided helpful comments on the manuscript. Gary Hettrick, Anita Golden, and Asher Siegelman expertly prepared figures. We also thank
Nemat Keyhani and Saul Roseman for a gift of chitobiose and
advice on GlcNAc assays. The participation of Caroline Ojaimi
in some aspects of the transcription studies is acknowledged. This work
was supported in part by grants AR41511 and AI45801 from the National
Institutes of Health (to I.S.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: 903 S. 4th St.,
Hamilton, MT 59840. Phone: (406) 363-9239. Fax: (406) 363-9394. E-mail: ktilly{at}nih.gov.
Present address: U.S. Meat Animal Research Center, USDA, ARS, Clay
Center, NE 68933.
 |
REFERENCES |
| 1.
|
Barbour, A. G.
1984.
Isolation and cultivation of Lyme disease spirochetes.
Yale J. Biol. Med.
57:521-525[Medline].
|
| 2.
|
Barbour, A. G., and S. F. Hayes.
1986.
Biology of Borrelia species.
Microbiol. Rev.
50:381-400[Free Full Text].
|
| 3.
|
Barbour, A. G.,
W. J. Todd, and H. G. Stoenner.
1982.
Action of penicillin on Borrelia hermsii.
Antimicrob. Agents Chemother.
21:823-829[Abstract/Free Full Text].
|
| 4.
|
Bono, J. L.,
A. F. Elias,
J. J. Kupko III,
B. Stevenson,
K. Tilly, and P. Rosa.
2000.
Efficient targeted mutagenesis in Borrelia burgdorferi.
J. Bacteriol.
182:2445-2452[Abstract/Free Full Text].
|
| 5.
|
Bono, J. L.,
K. Tilly,
B. Stevenson,
D. Hogan, and P. Rosa.
1998.
Oligopeptide permease in Borrelia burgdorferi: putative peptide-binding components encoded by both chromosomal and plasmid loci.
Microbiology
144:1033-1044[Abstract/Free Full Text].
|
| 6.
|
Bruck, D. K.,
M. L. Talbot,
R. G. Cluss, and J. T. Boothby.
1995.
Ultrastructural characterization of the stages of spheroplast preparation of Borrelia burgdorferi.
J. Microbiol. Methods
23:219-228[CrossRef].
|
| 7.
|
Casjens, S.,
R. van Vugt,
K. Tilly,
P. A. Rosa, and B. Stevenson.
1997.
Homology throughout the multiple 32-kilobase circular plasmids present in Lyme disease spirochetes.
J. Bacteriol.
179:217-227[Abstract/Free Full Text].
|
| 8.
|
de Silva, A. M., and E. Fikrig.
1995.
Growth and migration of Borrelia burgdorferi in Ixodes ticks during blood feeding.
Am. J. Trop. Med. Hyg.
53:397-404.
|
| 8a.
|
Dever, L. L.,
J. L. Jorgensen, and A. G. Barbour.
1993.
In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.
Antimicrob. Agents Chemother.
37:1115-1121[Abstract/Free Full Text].
|
| 9.
|
Elias, A. F.,
J. L. Bono,
J. A. Carroll,
P. Stewart,
K. Tilly, and P. Rosa.
2000.
Altered stationary phase response in a Borrelia burgdorferi rpoS mutant.
J. Bacteriol.
182:2909-2918[Abstract/Free Full Text].
|
| 10.
|
Escudero, R.,
M. L. Halluska,
P. B. Backenson,
J. L. Coleman, and J. L. Benach.
1997.
Characterization of the physiological requirements for the bactericidal effects of a monoclonal antibody to OspB of Borrelia burgdorferi by confocal microscopy.
Infect. Immun.
65:1908-1915[Abstract].
|
| 11.
|
Fournier, T.,
N. N. Medjoubi, and D. Porquet.
2000.
Alpha-1-acid glycoprotein.
Biochim. Biophys. Acta
1482:157-171[CrossRef][Medline].
|
| 12.
|
Fraser, C. M.,
S. Casjens,
W. M. Huang,
G. G. Sutton,
R. Clayton,
R. Lathigra,
O. White,
K. A. Ketchum,
R. Dodson,
E. K. Hickey,
M. Gwinn,
B. Dougherty,
J.-F. Tomb,
R. D. Fleischmann,
D. Richardson,
J. Peterson,
A. R. Kerlavage,
J. Quackenbush,
S. Salzberg,
M. Hanson,
R. van Vugt,
N. Palmer,
M. D. Adams,
J. Gocayne,
J. Weidmann,
T. Utterback,
L. Watthey,
L. McDonald,
P. Artiach,
C. Bowman,
S. Garland,
C. Fujii,
M. D. Cotton,
K. Horst,
K. Roberts,
B. Hatch,
H. O. Smith, and J. C. Venter.
1997.
Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi.
Nature
390:580-586[CrossRef][Medline].
|
| 13.
|
Kelly, R.
1971.
Cultivation of Borrelia hermsii.
Science
173:443-444[Abstract/Free Full Text].
|
| 14.
|
Keyhani, N. O., and S. Roseman.
1997.
Wild-type Escherichia coli grows on the chitin disaccharide, N,N'-diacetylchitobiose, by expressing the cel operon.
Proc. Natl. Acad. Sci. USA
94:14367-14371[Abstract/Free Full Text].
|
| 15.
|
Keyhani, N. O.,
L. X. Wang,
Y. C. Lee, and S. Roseman.
1996.
The chitin catabolic cascade in the marine bacterium Vibrio furnissii. Characterization of an N,N'-diacetyl-chitobiose transport system.
J. Biol. Chem.
271:33409-33413[Abstract/Free Full Text].
|
| 16.
|
Lai, X., and L. O. Ingram.
1993.
Cloning and sequencing of a cellobiose phosphotransferase system operon from Bacillus stearothermophilus XL-65-6 and functional expression in Escherichia coli.
J. Bacteriol.
175:6441-6450[Abstract/Free Full Text].
|
| 17.
|
Lane, R. S.,
J. Piesman, and W. Burgdorfer.
1991.
Lyme borreliosis: relation of its causative agent to its vectors and hosts in North America and Europe.
Annu. Rev. Entomol.
36:587-609[CrossRef][Medline].
|
| 18.
|
Ohnishi, J.,
J. Piesman, and A. M. de Silva.
2001.
Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks.
Proc. Natl. Acad. Sci. USA
98:670-675[Abstract/Free Full Text].
|
| 19.
|
Pavelka, M. S., Jr., and W. R. Jacobs, Jr.
1996.
Biosynthesis of diaminopimelate, the precursor of lysine and a component of peptidoglycan, is an essential function of Mycobacterium smegmatis.
J. Bacteriol.
178:6496-6507[Abstract/Free Full Text].
|
| 20.
|
Piesman, J.
1993.
Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks.
J. Infect. Dis.
167:1082-1085[Medline].
|
| 21.
|
Piesman, J.,
J. R. Oliver, and R. J. Sinsky.
1990.
Growth kinetics of the Lyme disease spirochete (Borrelia burgdorferi) in vector ticks (Ixodes dammini).
Am. J. Trop. Med. Hyg.
42:352-357.
|
| 22.
|
Reissig, J. L.,
J. L. Strominger, and L. F. Leloir.
1955.
A modified colorimetric method for the estimation of N-acetylamino sugars.
J. Biol. Chem.
217:959-966[Free Full Text].
|
| 23.
|
Rosa, P.,
D. S. Samuels,
D. Hogan,
B. Stevenson,
S. Casjens, and K. Tilly.
1996.
Directed insertion of a selectable marker into a circular plasmid of Borrelia burgdorferi.
J. Bacteriol.
178:5946-5953[Abstract/Free Full Text].
|
| 24.
|
Rudzinska, M. A.,
A. Spielman,
S. Lewengrub,
J. Piesman, and S. Karakashian.
1982.
Penetration of the peritrophic membrane of the tick by Babesia microti.
Cell Tissue Res.
221:471-481[Medline].
|
| 25.
|
Samuels, D. S.
1995.
Electrotransformation of the spirochete Borrelia burgdorferi, p. 253-259.
In
J. A. Nickoloff (ed.), Methods in molecular biology. Humana Press, Inc., Totowa, N.J.
|
| 26.
|
Schwan, T. G.,
J. Piesman,
W. T. Golde,
M. C. Dolan, and P. A. Rosa.
1995.
Induction of an outer surface protein on Borrelia burgdorferi during tick feeding.
Proc. Natl. Acad. Sci. USA
92:2909-2913[Abstract/Free Full Text].
|
| 27.
|
Sonenshine, D. E.
1991.
Biology of ticks, p. 95-97.
Oxford University Press, New York, N.Y.
|
| 28.
|
Tilly, K.,
S. Casjens,
B. Stevenson,
J. L. Bono,
D. S. Samuels,
D. Hogan, and P. Rosa.
1997.
The Borrelia burgdorferi circular plasmid cp26: conservation of plasmid structure and targeted inactivation of the ospC gene.
Mol. Microbiol.
25:361-373[CrossRef][Medline].
|
| 29.
|
Tilly, K.,
L. Lubke, and P. Rosa.
1998.
Characterization of circular plasmid dimers in Borrelia burgdorferi.
J. Bacteriol.
180:5676-5681[Abstract/Free Full Text].
|
| 30.
|
Vieira, J., and J. Messing.
1991.
New pUC-derived cloning vectors with different selectable markers and DNA replication origins.
Gene
100:189-194[CrossRef][Medline].
|
| 31.
|
Yang, X.,
M. S. Goldberg,
T. G. Popova,
G. B. Schoeler,
S. K. Wikel,
K. E. Hagman, and M. V. Norgard.
2000.
Interdependence of environmental factors influencing reciprocal patterns of gene expression in virulent Borrelia burgdorferi.
Mol. Microbiol.
37:1470-1479[CrossRef][Medline].
|
| 32.
|
Zhu, Z.,
L. Gern, and A. Aeschlimann.
1991.
The peritrophic membrane of Ixodes ricinus.
Parasitol. Res.
77:635-641[CrossRef][Medline].
|
Journal of Bacteriology, October 2001, p. 5544-5553, Vol. 183, No. 19
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.19.5544-5553.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bakker, R. G., Li, C., Miller, M. R., Cunningham, C., Charon, N. W.
(2007). Identification of Specific Chemoattractants and Genetic Complementation of a Borrelia burgdorferi Chemotaxis Mutant: Flow Cytometry-Based Capillary Tube Chemotaxis Assay. Appl. Environ. Microbiol.
73: 1180-1188
[Abstract]
[Full Text]
-
Tourand, Y., Bankhead, T., Wilson, S. L., Putteet-Driver, A. D., Barbour, A. G., Byram, R., Rosa, P. A., Chaconas, G.
(2006). Differential Telomere Processing by Borrelia Telomere Resolvases In Vitro but Not In Vivo. J. Bacteriol.
188: 7378-7386
[Abstract]
[Full Text]
-
Li, X., Liu, X., Beck, D. S., Kantor, F. S., Fikrig, E.
(2006). Borrelia burgdorferi Lacking BBK32, a Fibronectin-Binding Protein, Retains Full Pathogenicity.. Infect. Immun.
74: 3305-3313
[Abstract]
[Full Text]
-
Stewart, P. E., Hoff, J., Fischer, E., Krum, J. G., Rosa, P. A.
(2004). Genome-Wide Transposon Mutagenesis of Borrelia burgdorferi for Identification of Phenotypic Mutants. Appl. Environ. Microbiol.
70: 5973-5979
[Abstract]
[Full Text]
-
Byram, R., Stewart, P. E., Rosa, P.
(2004). The Essential Nature of the Ubiquitous 26-Kilobase Circular Replicon of Borrelia burgdorferi. J. Bacteriol.
186: 3561-3569
[Abstract]
[Full Text]
-
Grimm, D., Tilly, K., Byram, R., Stewart, P. E., Krum, J. G., Bueschel, D. M., Schwan, T. G., Policastro, P. F., Elias, A. F., Rosa, P. A.
(2004). Outer-surface protein C of the Lyme disease spirochete: A protein induced in ticks for infection of mammals. Proc. Natl. Acad. Sci. USA
101: 3142-3147
[Abstract]
[Full Text]
-
Frank, K. L., Bundle, S. F., Kresge, M. E., Eggers, C. H., Samuels, D. S.
(2003). aadA Confers Streptomycin Resistance in Borrelia burgdorferi. J. Bacteriol.
185: 6723-6727
[Abstract]
[Full Text]
-
Stewart, P. E., Chaconas, G., Rosa, P.
(2003). Conservation of Plasmid Maintenance Functions between Linear and Circular Plasmids in Borrelia burgdorferi. J. Bacteriol.
185: 3202-3209
[Abstract]
[Full Text]
-
Ojaimi, C., Brooks, C., Casjens, S., Rosa, P., Elias, A., Barbour, A., Jasinskas, A., Benach, J., Katona, L., Radolf, J., Caimano, M., Skare, J., Swingle, K., Akins, D., Schwartz, I.
(2003). Profiling of Temperature-Induced Changes in Borrelia burgdorferi Gene Expression by Using Whole Genome Arrays. Infect. Immun.
71: 1689-1705
[Abstract]
[Full Text]
-
Elias, A. F., Stewart, P. E., Grimm, D., Caimano, M. J., Eggers, C. H., Tilly, K., Bono, J. L., Akins, D. R., Radolf, J. D., Schwan, T. G., Rosa, P.
(2002). Clonal Polymorphism of Borrelia burgdorferi Strain B31 MI: Implications for Mutagenesis in an Infectious Strain Background. Infect. Immun.
70: 2139-2150
[Abstract]
[Full Text]